Skip to main content
AAN.com
Research Article
January 12, 2022
Open AccessinfographicLetter to the Editor

Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease

February 22, 2022 issue
98 (8) e859-e871

Related Infographic

Letters to the Editor
27 February 2022
Author Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
Kazuto Tsukita, Neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Haruhi Sakamaki-Tsukita, Neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Ryosuke Takahashi, Professor, neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

We thank Dr. Grippe and colleagues for the constructive comment on our article.1 Along with highlighting important references,2,3 they reasonably urged caution in the interpretation of our results based on the inherent limitation of observational studies that "reverse causation" cannot be ruled out. These authors also note concern for the use of the Physical Activity Scale for the Elderly questionnaire to quantify regular physical activity and exercise habits. We fully agree with these points.

We believe that the only way to overcome these two limitations is to conduct a well-designed intervention trial combined with objective monitoring of exercise intensity. Although our study only examined association, we believe it provides important indications of the importance of maintaining physical activity, and the possibility that different physical activities may be beneficial for different clinical symptoms. We hope that the results of our study will help guide future trials to place emphasis on continuous exercise, which is possible now that internet-based applications are developed and widespread,4,5 as well as the differential effects of exercise.

Disclosure

The authors report no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Tsukita K, Sakamaki-Tsukita H, Takahashi R. Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease. Neurology. 2022;98(8):e859-e871. doi:10.1212/WNL.0000000000013218
  2. van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, et al. Physical inactivity in Parkinson's disease. J Neurol. 2011;258(12):2214-2221. doi:10.1007/s00415-011-6097-7
  3. Mantri S, Wood S, Duda JE, Morley JF. Comparing self-reported and objective monitoring of physical activity in Parkinson disease. Parkinsonism Relat Disord. 2019;67:56-59. doi:10.1016/j.parkreldis.2019.09.004
  4. Ellis TD, Cavanaugh JT, DeAngelis T, et al. Comparative Effectiveness of mHealth-Supported Exercise Compared With Exercise Alone for People With Parkinson Disease: Randomized Controlled Pilot Study. Phys Ther. 2019;99(2):203-216. doi:10.1093/ptj/pzy131
  5. van der Kolk NM, de Vries NM, Kessels RPC, et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial. Lancet Neurol. 2019;18(11):998-1008. doi:10.1016/S1474-4422(19)30285-6
20 February 2022
Author Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
Kazuto Tsukita, Neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Haruhi Sakamaki-Tsukita, Neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Ryosuke Takahashi, Professor, neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

We thank Dr. Gupta for the comment on our article,1 which requested further elucidation of the biological basis of the effect of exercise, especially in relation to α-synuclein toxicity.2 The comment also highlighted the importance of motivation for continued engagement in physical activities.
The results of our study support the long-term effects of exercise, although the possibility of reverse causality cannot be denied. Whether these effects are "symptomatic" or "disease-modifying" warrants further studies in future. In this respect, further clinical trials with a delayed-start design, imaging studies exploring changes in the brain network after exercise, and animal studies exploring the effect of exercise on disease-relevant changes in Parkinson disease (PD) including α-synuclein pathology are important.3-5

In addition, we believe that future research should clarify the impact of different motivations for exercise in the course of PD and strategies to support long-term motivation of PD patients; for example, through remote supervision using mobile applications. We hope that further research in this direction will eventually lead to the establishment of strategies that enable PD patients to live better lives through physical activity and exercise.

Disclosure

The authors report no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Tsukita K, Sakamaki-Tsukita H, Takahashi R. Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease [published online ahead of print, 2022 Jan 12]. Neurology. 2022;10.1212/WNL.0000000000013218.
  2. Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R. Value of in vivo α-synuclein deposits in Parkinson's disease: A systematic review and meta-analysis. Mov Disord. 2019;34(10):1452-1463. doi:10.1002/mds.27794
  3. Rascol O. "Disease-modification" trials in Parkinson disease: target populations, endpoints and study design. Neurology. 2009;72(7 Suppl):S51-S58. doi:10.1212/WNL.0b013e318199049e
  4. Mak MK, Wong-Yu IS, Shen X, Chung CL. Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol. 2017;13(11):689-703. doi:10.1038/nrneurol.2017.128
  5. Espay AJ, Kalia LV, Gan-Or Z, et al. Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?. Neurology. 2020;94(11):481-494. doi:10.1212/WNL.0000000000009107
12 February 2022
Author Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
Kazuto Tsukita, Neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Haruhi Sakamaki-Tsukita, Neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Ryosuke Takahashi, Professor, neurologist| Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

We thank Darweesh et al. for their comment on our article.1 Due to the observational nature of our study, the possibility of reverse causality or that it reflects a symptomatic effect cannot be denied. However, in light of the recent highlighted evidence,2 it is quite possible that the results demonstrate the disease-modifying effects of physical activities. In addition to our study, a recent study showed that exercise may change the brain network to some extent, thus providing additional support for the possible disease-modifying effects of exercise and physical activities.3

We hope that this study will motivate patients with Parkinson's disease to keep engaging in physical activities and inspire future randomized clinical trials (RCTs) to focus on sustained exercise, for example, via remote supervision.2,4 We also hope that in the future those RCTs will include many ethnic groups through international multi-center studies,5 and a way to modify the pathogenesis of PD and delay its onset through exercise and physical activities will eventually be found for PD patients and "prodromal" subjects all over the world.

Disclosure

The authors report no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Tsukita K, Sakamaki-Tsukita H, Takahashi R. Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease [published online ahead of print, 2022 Jan 12]. Neurology. 2022;10.1212/WNL.0000000000013218.
  2. de Vries NM, Darweesh SKL, Bloem BR. Citius, Fortius, Altius-Understanding Which Components Drive Exercise Benefits in Parkinson Disease. JAMA Neurol. 2021;78(12):1443-1445. doi:10.1001/jamaneurol.2021.3744
  3. Johansson ME, Cameron IGM, Van der Kolk NM, et al. Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial. Ann Neurol. 2022;91(2):203-216. doi:10.1002/ana.26291
  4. van der Kolk NM, de Vries NM, Kessels RPC, et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial. Lancet Neurol. 2019;18(11):998-1008. doi:10.1016/S1474-4422(19)30285-6
  5. Lau YH, Podlewska A, Ocloo J, et al. Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson's Disease? [published online ahead of print, 2022 Jan 21]. J Parkinsons Dis. 2022;10.3233/JPD-213113. doi:10.3233/JPD-213113
7 February 2022
Reader Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
Talyta Cortez Grippe, Research Fellow| Krembil Research Institute, Toronto Western Hospital
Connie Marras, Assistant Professor of Neurology, Neurologist| Movement Disorders Clinic, Toronto Western Hospital; Division of Neurology, University of Toronto
Miriam Rafferty, Research Scientist, Assistant Professor of Physical Medicine and Rehabilitation| Shirley Ryan AbilityLab; Department of Physical Rehabilitation and Medicine, Northwestern University
Anthony E Lang, Professor of Neurology , Neurologist| Movement Disorders Clinic, Toronto Western Hospital; Division of Neurology, University of Toronto

Dr. Tsukita and colleagues’ PPMI database analysis reports the effects of physical activity on the progression of PD clinical parameters, measured using the Physical Activity Scale for the Elderly (PASE). It confirms prior studies showing that regular exercise is associated with improved outcomes.2 Although the study uses rigorous statistical methods, the reported association between maintained physical activity and concurrent slower deterioration of postural and gait stability should be interpreted carefully.

The authors emphasize the mechanisms by which exercise may improve outcomes; the title implies causation. However, impaired postural and gait stability are well known to affect physical activity in PD.3 Many of the activities listed in the PASE require good balance. Thus, postural and gait impairments could be responsible for reducing exercise. We believe this reverse causation is a critical factor to consider before assuming that the reduced rate of posture and gait deterioration is a direct effect of the amount and regularity of the exercise performed.

Additionally, the PASE questionnaire, based on a 1-week recall, is limited by lower reliability than questionnaires with longer timeframes and only moderate correlation with objective activity monitoring in people with PD.4,5 Psychometrically strong, clinical measures of physical activity are needed.

Disclosure

The authors report no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Tsukita K, Sakamaki-Tsukita H, Takahashi R. Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease [published online ahead of print, 2022 Jan 12]. Neurology. 2022;10.1212/WNL.0000000000013218.
  2. Rafferty MR, Schmidt PN, Luo ST, et al. Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data. J Parkinsons Dis. 2017;7(1):193-202. doi:10.3233/JPD-160912
  3. van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, et al. Physical inactivity in Parkinson's disease. J Neurol. 2011;258(12):2214-2221. doi:10.1007/s00415-011-6097-7
  4. Ånfors S, Kammerlind AS, Nilsson MH. Test-retest reliability of physical activity questionnaires in Parkinson's disease. BMC Neurol. 2021;21(1):399. Published 2021 Oct 15. doi:10.1186/s12883-021-02426-y
  5. Mantri S, Wood S, Duda JE, Morley JF. Comparing self-reported and objective monitoring of physical activity in Parkinson disease. Parkinsonism Relat Disord. 2019;67:56-59. doi:10.1016/j.parkreldis.2019.09.004
25 January 2022
Reader Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
Vinod K Gupta, Physician-Medical Director| GUPTA MEDICAL CENTRE, MIGRAINE-HEADACHE INSTITUTE, S-407, Greater Kailash-Part Two, New Delhi, INDIA-110048

Tsukita et al. emphasize the value of regular physical activity and exercise habits for improving the clinical course of Parkinson disease (PD), with each type of physical activity offering different benefits. Their study also recommends a change in attitude towards exercise as therapy.1

In the absence of further evolution of the interrelated pathophysiologic processes linked to PD, exercise (like stress) remains a mechanistic euphemism.2 The greater the lack of clarity on related alteration of pathophysiological mechanisms, the more attractive the therapeutic role for exercise (high/low impact) becomes.2,3 Even randomized controlled trials or meta-analyses including exercise do not supplant the need for the therapy to be placed in a biologically-plausible, overarching theoretical matrix.3,4 In order for exercise to emerge as a scientifically valid therapy for non-motor and motor symptoms of PD, it is essential to maintain hyperfocus on toxicity and the spread of α-synuclein.

Motivation is a key factor for evaluating benefits of staying physically active in health and disease.5 Basal and stimulated motivation for exercise varies widely between individuals. Comparison of a cohort of PD patients with and without motivation profile for a particular physical exercise is important to critically differentiate the value of such therapy.5

Disclosure

The author reports no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Tsukita K, Sakamaki-Tsukita H, Takahashi R. Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease [published online ahead of print, 2022 Jan 12]. Neurology. 2022;10.1212/WNL.0000000000013218.
  2. Gupta VK. Pathophysiology of migraine: An increasingly complex narrative to 2020. Future Neurology. 2019;14(2). doi:10.2217/fnl-2019-0003
  3. Barber M, Pace A. Exercise and Migraine Prevention: a Review of the Literature. Curr Pain Headache Rep. 2020;24(8):39. Published 2020 Jun 11. doi:10.1007/s11916-020-00868-6
  4. Gupta VK. Patent foramen ovale closure and migraine: science and sensibility. Expert Rev Neurother. 2010;10(9):1409-1422. doi:10.1586/ern.10.125
  5. Ferri-Caruana A, Millán-González L, García-Massó X, Pérez-Nombela S, Pellicer-Chenoll M, Serra-Añó P. Motivation to Physical Exercise in Manual Wheelchair Users With Paraplegia. Top Spinal Cord Inj Rehabil. 2020;26(1):1-10. doi:10.1310/sci2601-01
14 January 2022
Reader Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
Sirwan Darweesh, Postdoctoral researcher, Epidemiologist| Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center
Nienke De Vries, Postdoctoral Researcher, Physiotherapist| Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center
Bas Bloem, Professor of Neurology| Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center

The study by Tsukita et al. explores the prolonged benefits of vigorous exercise for patients with Parkinson Disease over long intervals (>5 years).1 This research builds on two recent trials, which demonstrate that engaging in vigorous exercise stabilizes the clinical progression of Parkinson’s Disease (PD) over 6 months.2,3 The study also suggests that maintaining a high total volume of physical activities, even at low intensity, may yield additional benefits.

Since this was not a randomized controlled trial, some of the observed associations may reflect reverse causality. However, taken together with the results from animal models, previous observational studies, and two clinical trials, there is now converging evidence that regularly engaging in exercise may slow the progression of PD.4 This should not only motivate people with PD to be physically active, but could also open up avenues for prevention of PD.

Prospective studies show that vigorous exercise and a high total volume of physical activities are both associated with a reduced risk of PD.5 A possible explanation is that exercise may slow the pathological processes of PD already during the decade-long prodromal phase of the disease. The findings by Tsukita et al. should inspire intervention studies for patients suspected of having prodromal PD, to determine whether regular exercise over long intervals may prevent or delay the manifestation of overt clinical symptoms of PD.

Disclosure

The authors report no relevant disclosures. Contact [email protected] for full disclosures.  

References

  1. Tsukita K, Sakamaki-Tsukita H, Takahashi R. Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease [published online ahead of print, 2022 Jan 12]. Neurology. 2022;10.1212/WNL.0000000000013218.
  2. van der Kolk NM, de Vries NM, Kessels RPC, et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial. Lancet Neurol. 2019;18(11):998-1008. doi:10.1016/S1474-4422(19)30285-6
  3. Schenkman M, Moore CG, Kohrt WM, et al. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018;75(2):219-226. doi:10.1001/jamaneurol.2017.3517
  4. de Vries NM, Darweesh SKL, Bloem BR. Citius, Fortius, Altius-Understanding Which Components Drive Exercise Benefits in Parkinson Disease. JAMA Neurol. 2021;78(12):1443-1445. doi:10.1001/jamaneurol.2021.3744
  5. Fang X, Han D, Cheng Q, et al. Association of Levels of Physical Activity With Risk of Parkinson Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2018;1(5):e182421. Published 2018 Sep 7. doi:10.1001/jamanetworkopen.2018.2421

Information & Authors

Information

Published In

Neurology®
Volume 98Number 8February 22, 2022
Pages: e859-e871
PubMed: 35022304

Publication History

Received: July 9, 2021
Accepted: November 30, 2021
Published online: January 12, 2022
Published in print: February 22, 2022

Permissions

Request permissions for this article.

Disclosure

R. Takahashi reports grants and personal fees from Takeda Pharma, Boeringer Ingelheim, Dainippon Sumito Pharma, Kyowa-Kirin Pharma, Eisai Pharma, Otsuka Pharma, Novartis, Sanofi, Kan Institute, and Nihon Medi-physics; grants from Astellas Pharma; personal fees from Abbvie, Mylan, JBO, Sanwa Kagaku, FP Pharma, Tsumura, Kissei, Chugai Pharma, and Biogen, outside the submitted work. The remaining authors (K. Tsukita and H. Sakamaki-Tsukita) report no disclosures. Go to Neurology.org/N for full disclosures.

Study Funding

This work was supported by JST [Moonshot R&D] [Grant Number JPMJMS2024].

Authors

Affiliations & Disclosures

From the Department of Neurology (K.T., H.S.-T., R.T.), Graduate School of Medicine, Kyoto University; Division of Sleep Medicine (K.T.), Kansai Electric Power Medical Research Institute, Osaka; and Laboratory of Barriology and Cell Biology (K.T.), Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Haruhi Sakamaki-Tsukita, MD
From the Department of Neurology (K.T., H.S.-T., R.T.), Graduate School of Medicine, Kyoto University; Division of Sleep Medicine (K.T.), Kansai Electric Power Medical Research Institute, Osaka; and Laboratory of Barriology and Cell Biology (K.T.), Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Ryosuke Takahashi, MD, PhD
From the Department of Neurology (K.T., H.S.-T., R.T.), Graduate School of Medicine, Kyoto University; Division of Sleep Medicine (K.T.), Kansai Electric Power Medical Research Institute, Osaka; and Laboratory of Barriology and Cell Biology (K.T.), Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.
Disclosure
Scientific Advisory Boards:
1.
(1) KAN Research Institute INC., Scientific Advisory Board (2) CHUGAI PHARMA., Scientific Advisory Board (3)ONO PHARMA., Scientific Advisory Board
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Novartis Pharma Japan, honoraria for lectures (2) Boehringer Ingelheim Japan, honoraria for lectures (3)Ono PHARMA (4) Dainippon Sumitomo Pharma, honoraria for lectures (5) FP pharmaceuticals, honoraria for lectures (6) Mitsubishi Tanabe Pharma, honoraria for lectures (7) Kyowa Kirin Co., honoraria for lectures (8) Otsuka Pharmaceutical Co., honoraria for lectures (9) Takeda Pharma, honoraria for lectures (10)Abbvie honoraria for lectures (11)Eisai Pharma, honoraria for lectures
Editorial Boards:
1.
(1) Journal of Neural Transmission, Editorial Board, 11 years (2) Neurology and Clinical Neuroscience, Editorial Board, 6 years (3) Translational Neurodegeneration, Editorial Board, 4 years (4) Movement Disorders, Editorial Board, 6 years (5) Molecular Brain, Editorial Board, 3 year
Patents:
1.
(1) The use of Mutant mouse of Chimaerin for drug screening (2) Drug Screening using iPS cells
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Novartis Pharma Japan (2) Boehringer Ingelheim Japan (3) Dainippon Sumitomo Pharma (4)Eisai Pahrma (5)Takeda Pharma
Research Support, Government Entities:
1.
(1) Ministry of Education, Culture, Sports, Science and Technology, Japan (2) Ministry of health labor and welfare, Japan (3) Japan Agency for Medical Research and Development
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Tsukita [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
The Article Processing Charge was funded by the authors.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Treatment of Apathy in Parkinson’s Disease and Implications for Underlying Pathophysiology, Journal of Clinical Medicine, 13, 8, (2216), (2024).https://doi.org/10.3390/jcm13082216
    Crossref
  2. A Comprehensive Approach to Parkinson’s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects, International Journal of Molecular Sciences, 25, 13, (7183), (2024).https://doi.org/10.3390/ijms25137183
    Crossref
  3. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology, International Journal of Molecular Sciences, 25, 8, (4358), (2024).https://doi.org/10.3390/ijms25084358
    Crossref
  4. Exercise, Neuroprotective Exerkines, and Parkinson’s Disease: A Narrative Review, Biomolecules, 14, 10, (1241), (2024).https://doi.org/10.3390/biom14101241
    Crossref
  5. MoveONParkinson: developing a personalized motivational solution for Parkinson’s disease management, Frontiers in Public Health, 12, (2024).https://doi.org/10.3389/fpubh.2024.1420171
    Crossref
  6. Considerations on How to Prevent Parkinson’s Disease Through Exercise, Journal of Parkinson's Disease, 14, s2, (S395-S406), (2024).https://doi.org/10.3233/JPD-240091
    Crossref
  7. Digital Intervention Promoting Physical Activity in People Newly Diagnosed with Parkinson’s Disease: Feasibility and Acceptability of the Knowledge, Exercise-Efficacy and Participation (KEEP) Intervention, Journal of Parkinson's Disease, 14, 6, (1193-1210), (2024).https://doi.org/10.3233/JPD-240071
    Crossref
  8. Parkinson’s Disease is Predominantly a Genetic Disease, Journal of Parkinson's Disease, 14, 3, (467-482), (2024).https://doi.org/10.3233/JPD-230376
    Crossref
  9. Dietary Interventions in Parkinson’s Disease, Journal of Parkinson's Disease, 14, 1, (1-16), (2024).https://doi.org/10.3233/JPD-230366
    Crossref
  10. Alleviating Stress in Parkinson’s Disease: Symptomatic Treatment, Disease Modification, or Both?, Journal of Parkinson's Disease, 14, s1, (S147-S158), (2024).https://doi.org/10.3233/JPD-230211
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

View Short Form

Full Text HTML

View Full Text HTML
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

Media

Figures

Other

Tables

Share

Share

Share article link

Share